YOLFTbeta
Dimerix Ltd

Dimerix Ltd

DXB · AU · Healthcare / Biotechnology

0.20AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.20
Open0.20
Day Range0.20 – 0.21
52-Week Range0.1575 – 0.665
Volume739.75K
Market Cap135.09M
P/E (TTM)0.00
Forward P/E10.78
EPS-0.05
Dividend Yield0.00%
Beta0.34
50-Day Avg0.2671
200-Day Avg0.3279

About

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease; as well as DMX-652 for the treatment of acute kidney injury. The company is headquartered in Fitzroy, Australia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Nina Webster B.Sc., M.B.A., M.IP.Law, Ph.D.
  • Employees15
  • Headquarters425 Smith Street, Fitzroy, VIC, Australia, 3065, Australia
  • Websitehttps://dimerix.com

Leadership

  • Dr. Nina Webster B.Sc., M.B.A., M.IP.Law, Ph.D.CEO, MD & Director
  • Mr. Michael Tonroe ACA, B.Sc., Bsc(Hons), F.C.A., M.A.I.C.D.CFO & Company Secretary · b. 1967
  • Dr. Robert ShepherdChief Operating Officer
  • Dr. David Everett Fuller BPharm, M.D., MBBSChief Medical Officer · b. 1964
  • Mr. Kevin Donald George Pfleger BA (Hons), MA, Ph.D.Chief Scientific Advisor

Financials

Income Statement

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-04-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue-----------8.09M5.34M4.09M2.49M2.71M1.37M564655.99K756.96K33.00K58.00K73.07K31.00K88.97K350.22K41.00K238.05K610.27K554.62K845.29K1.45M2.34M4.44M6.46M36.79K583.48K1.25M4.35M
Growth (%)-------------33.96%-23.43%-39.21%+8.77%-49.39%-99.96%+116210.82%+15.39%-95.64%+75.76%+25.98%-57.57%+187.01%+293.62%-88.29%+480.62%+156.36%-9.12%+52.41%+71.18%+61.78%+89.66%+45.56%-99.43%+1486.10%+115.02%+246.75%
Cost of Revenue------------3.32M2.37M1.36M1.53M1.08M-109.77K314.81K----177.29K86.81K86.81K1.02K1.91K1.52K6.42K4.68K13.53K44.60K50.55K56.01K--138.16K
Gross Profit------------2.02M1.72M1.13M1.18M286.29K564546.22K442.14K--73.07K--88.32K263.41K263.41K238.05K608.36K553.10K838.87K1.44M2.33M4.39M6.41M36.79K583.48K1.25M4.21M
Gross Margin------------37.84%42.04%45.44%43.48%20.91%100.00%83.27%58.41%--100.00%--99.26%75.21%642.46%100.00%99.69%99.73%99.24%99.72%99.40%98.99%99.23%100.00%100.00%100.00%96.82%
Operating Expense------------7.55M2.49M2.11M1.80M1.82M3.09M3.04M3.18M--474.88K-372.70K483.30K853.61K763.05K2.50M2.87M5.00M5.78M9.24M15.32M16.91M22.86M25.82M37.60M41.39M
Operating Income161.00K-118.00K-554.00K2.00K-40.00K-110.00K-100.00K-87.65K-105.71K703.97K1.12M-151.00K-5.53M-771.00K-983.00K-626.00K-1.53M-3.09M-2.50M-2.74M-512.43K-404.50K-401.82K-417.44K-461.01K-219.89K-590.20K-525.00K-1.89M-2.31M-4.17M-4.33M-6.92M-10.93M-10.49M-22.82M-25.24M-36.34M-37.18M
Operating Margin------------1.87%-103.41%-18.85%-39.53%-23.14%-112.05%-547143.62%-380.80%-361.98%-1552.82%-697.41%-549.92%-1346.59%-518.15%-62.79%-1439.51%-220.54%-309.70%-417.04%-492.73%-299.52%-295.51%-246.13%-162.35%-62040.94%-4325.06%-2896.65%-854.60%
EBITDA161.00K-118.00K-554.00K2.00K-40.00K-110.00K-100.00K-87.65K-105.71K703.97K1.12M-133.72K-4.00M-571.00K-777.00K-465.00K-484.00K-11.16M-1.88M-2.19M-111.00K-402.82K-401.82K-417.44K-461.01K--590.20K-579.00K-1.28M-2.29M-4.14M-4.31M-6.82M-10.02M-16.47M-22.68M-24.96M-36.22M-37.04M
EBITDA Margin------------1.65%-74.92%-13.96%-31.24%-17.19%-35.35%-1977838.65%-287.20%-289.84%-336.36%-694.52%-549.92%-1346.59%-518.15%--1439.51%-243.22%-209.41%-413.44%-489.54%-297.93%-291.29%-225.74%-254.87%-61654.93%-4277.62%-2886.80%-851.43%
Net Income90.00K-119.00K-344.00K-1.00K-65.00K-137.00K-123.00K-123.00K-140.53K598.17K646.30K-516.95K-4.35M-740.00K-51.24K-676.00K-596.00K-11.16M-2.42M-3.56M-4.13M-347.77K5.66K-386.07K-517.10K-215.28K-527.98K-680.00K-5.25M-1.76M-3.32M-2.89M-4.49M-6.37M-10.49M-13.80M-17.07M-13.25M-29.81M
Net Income Margin------------6.39%-81.41%-18.09%-2.06%-24.99%-43.54%-1978903.90%-369.21%-469.91%-12511.33%-599.60%7.74%-1245.39%-581.19%-61.47%-1287.75%-285.65%-860.93%-317.16%-392.77%-199.45%-191.97%-143.51%-162.32%-37521.41%-2926.42%-1056.25%-685.32%
R&D----------------344.00K775.00K133.00K-----212.44K217.72K131.96K211.70K589.08K878.12K2.05M2.84M5.54M9.33M14.39M20.47M21.10M27.32M36.03M
R&D as % of Total Revenue----------------25.13%137411.35%20.27%-----238.77%62.17%321.86%88.93%96.53%158.33%242.64%196.06%236.57%210.18%222.64%55655.53%3615.90%2177.88%828.15%
Interest Expense08.00K8.00K6.00K1.00K27.00K23.00K35.85K34.82K7.75K27.07K58.36K161.68K95.53K103.48K149.41K99.18K10456.05K0000000000000001.16K----
Interest Expense % of Total Revenue-----------0.72%3.03%2.34%4.16%5.52%7.24%18.44%8.54%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.02%----

Balance Sheet

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-04-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets1.78M1.73M1.15M1.16M1.64M2.03M1.98M2.24M2.26M9.69M9.12M7.90M2.28M1.89M1.22M1.83M10.52M3.04M4.07M2.45M385.33K1.61M1.59M1.21M1.75M1.76M1.21M2.97M2.53M2.87M7.26M4.94M10.39M9.42M16.50M17.76M32.08M91.18M58.59M
Total Liabilities256.00K318.00K103.00K117.00K226.00K292.00K257.00K393.76K303.21K4.66M3.35M2.66M1.64M1.61M1.78M2.00M240.50K343.75K2.66M1.44M43.36K46.35K27.99K34.52K46.31K1.73M34.49K191.64K282.73K242.12K406.74K737.77K2.63M7.95M2.07M11.79M13.89M77.80M73.35M
Total Equity1.52M1.41M1.05M1.04M1.41M1.74M1.72M1.85M1.96M5.03M5.77M5.24M640.43K282.89K-565.02K-170.38K10.28M2.69M1.41M1.01M341.98K1.56M1.57M1.18M1.71M31.22K1.18M2.78M2.24M2.63M6.86M4.20M7.76M1.47M14.42M5.96M18.19M13.38M-14.76M
Cash21.00K10.00K8.00K213.00K30.00K80.00K47.00K172.81K82.00K1.28M87.00K17.00K245.00K42.00K51.00K136.00K2.24M1.13M446.33K118.22K371.67K1.16M1.03M154.33K1.15M1.67M1.20M2.93M2.02M2.24M6.28M3.56M7.79M5.25M9.63M7.99M22.14M68.28M16.15M
Total Debt-6.00K31.00K24.00K32.00K196.00K196.00K331.44K170.00K2.72M1.96M1.47M91.00K481.00K537.00K794.00K10.07K10.07K2.11M1.02M-----------1.09M1.06M5.09M73.10K5.96M149.68K97.48K232.09K
Net Debt-21.00K-4.00K23.00K-189.00K2.00K116.00K149.00K158.63K88.00K1.44M1.87M1.46M-154.00K439.00K486.00K658.00K-2.23M-1.12M1.66M899.85K-371.67K-1.16M-1.03M-154.33K-1.15M--1.20M-2.93M-2.02M-2.24M-6.28M-3.56M-6.73M-207.00K-9.56M-2.03M-21.99M-68.19M-15.92M

Cash Flow

Currency: AUD1989-06-301990-06-301991-06-301992-06-301993-06-301994-06-301995-06-301996-06-301997-06-301998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-04-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow---13.00K-35.00K-107.00K-123.00K-125.03K-171.60K-1.03M481.16K102.47K-603.82K-572.26K-902.37K-1.52M-2.01M-1.66M-2.40M-1.75M-373.67K-326.54K-232.33K-305.90K-558.55K-568.88K-558.55K-1.38M-1.86M-3.23M-2.75M-4.72M-6.46M-13.44M-12.73M-7.00M39.05M-51.81M
Investing Cash Flow-----146.00K-1.00K---2.62K-3.06M-2.45M-1.24M1.47M-129.43K83.28K-367.11K678.85K-293.93K-397.11K-60.76K-119.17K-399.98K194.43K-645.23K282.33K2.93M615.63K-93.43K2.93M-2.58K-3.54K-6.91K4.38K4.38K-10.61K-2.30K-15.80K-21.01K-4.98K
Financing Cash Flow----8.00K196.00K160.00K90.00K250.79K83.60K2.74M297.67K437.47K-1.10M530.73K498.28K1.35M2.94M1.21M1.38M2.13M2.12M1.57M--1.02M81.30K-2.37M-19.84K2.09M7.25M8.91M8.91M3.83M17.69M11.07M21.17M7.42M118.47K
Capital Expenditure000200.00K146.00K1.00K002.62K320.00K1.00M39.66K95.59K67.81K20.30K61.10K32.68K23.94K060.76K119.17K00001.98K05.88K1.98K2.58K3.54K6.91K9.57K9.57K10.61K2.30K15.80K21.01K4.98K
Free Cash Flow----187.00K-181.00K-108.00K-123.00K-125.03K-174.23K-320.00K26.95K441.50K6.87K-671.63K-592.56K-963.47K-1.55M-2.04M-1.66M-2.46M-1.87M-373.67K-326.54K-232.33K-305.90K--568.88K-564.43K-1.38M-1.87M-3.23M-2.76M-4.72M-6.47M-13.45M-12.73M-7.02M39.03M-51.81M
Dividends Paid--------165.16K665.80K612.25K74.49K--------------------8.48M1.24M1.40K10.68M---
FCF to OCF----1438.46%517.14%100.93%100.00%100.00%101.53%-2.61%91.76%6.71%111.23%103.55%106.77%102.15%101.19%100.00%102.53%106.82%100.00%100.00%100.00%100.00%-100.00%101.05%100.14%100.14%100.11%100.25%100.00%100.15%100.08%100.02%100.23%99.95%100.01%
Dividend Paid to FCF---------94.79%-208.06%2271.37%16.87%---------------------179.64%-19.16%-0.01%-83.85%---

Earnings

Report DateFeb 24, 2016Aug 24, 2016Feb 21, 2017Aug 30, 2017Feb 26, 2018Aug 30, 2018Feb 26, 2019Aug 29, 2019Feb 18, 2020Aug 26, 2020Feb 22, 2021Aug 15, 2021Feb 23, 2022Aug 28, 2022Feb 26, 2023Feb 24, 2025Aug 27, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.00----0.000.00
EPS Actual-0.07-0.01-0.01-0.01-0.02-0.01-0.01-0.01-0.02-0.01-0.02-0.01-0.02-0.01-0.03-0.020.00
Surprise-----------------
Timing-------After-hoursAfter-hoursAfter-hours--After-hoursAfter-hoursAfter-hours--

Key Statistics & Ratios

Market Cap135.09M
Enterprise Value125.17M
Trailing P/E0.00
Forward P/E10.78
PEG Ratio0.72
Price / Sales21.26
Price / Book24.45
EPS-0.05
Book Value-0.025
Revenue (TTM)6.35M
Gross Profit (TTM)6.35M
EBITDA-35.16M
Profit Margin0.00%
Operating Margin-317.50%
Return on Equity-594.54%
Return on Assets-29.36%
Shares Outstanding600.40M
Shares Float463.94M
Beta0.34
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

19992×
1.17Sep 24, 19993.52Apr 16, 1999
19981×
6.56Sep 16, 1998

Stock Splits

  • May 8, 2023172:169
  • Dec 8, 201721:20
  • Oct 23, 20171:20
  • Nov 13, 201220:17
  • Oct 4, 20121:14
  • Oct 23, 20095:3
  • Jul 3, 200827:25
  • Jun 26, 200728:27
  • Jan 24, 20052:5
  • Dec 14, 200114:11
  • Feb 9, 199526:25